Industry Advisory Committee (IAC)

The ELIXIR Industry Advisory Committee (IAC) provides advice and feedback on ELIXIR industry engagement activities. The committee consists of experts from the private sector ranging from SMEs to large multinational companies. Its twelve members are appointed by the ELIXIR Board. 

For 2023, the Chair of the ELIXIR IAC is Natalia Jiménez Lozano, supported by Filip Pattyn as Vice-Chair.

Name Affiliation
Ian Barrett AstraZeneca, UK
Thomas Exner Seven Past Nine GmbH, Germany
Andreas Kremer ITTM, Luxembourg
Natalia Jiménez Lozano (Chair) Atos, UK
Klaus Maisinger Illumina, UK
Geert de Meyer Waltham Petcare Science Institute, MARS UK, UK
Filip Pattyn (Vice-Chair) FAQIR, Belgium
Jörg Peplies Ribocon GmbH, Germany
Elizabeth Reynolds General Bioinformatics, UK
Philippe Sanseau GlaxoSmithKline, UK
Catherine Sirven Bayer, France
Bérénice Wulbrecht ONTOFORCE, Belgium

ELIXIR IAC and SAB members, February 2023

Members of the ELIXIR Industry Advisory Committee and Scientific Advisory Board, from left to right: Joana Wingender (Hub), Thomas Exner, Jerry Lanfear (Hub), Robert Gentleman (SAB), Ian Barrett, Filip Pattyn, Peter Maccallum (Hub), Serena Scollen (Hub), Doreen Ware (SAB), Jonathan Tedds (Hub), Nicola Mulder (SAB), Ivana Versic (Hub), Susan Wallace (SAB), Elina Ikonen (SAB), Geert de Meyer, Philip Bourne (SAB), Bérénice Wulbrecht, Janet Kelso (SAB), Niklas Blomberg (Hub), Natalia Jimenez, Francis Ouellette (SAB).

Previous Advisory Committee meetings & reports